Viewing Study NCT03608761


Ignite Creation Date: 2025-12-24 @ 11:46 AM
Ignite Modification Date: 2026-01-31 @ 7:55 AM
Study NCT ID: NCT03608761
Status: COMPLETED
Last Update Posted: 2018-12-04
First Post: 2018-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison Between Rebamipide 2% Versus Autologous Serum
Sponsor: Hospital Nacional Profesor Alejandro Posadas
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dry Eye Syndromes View
None Sjögren Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dry eye View
None Sjögren syndrome View
None Rebamipida 2% View
None autologous serum View